Molecular Diagnosis & Therapy

Papers
(The TQCC of Molecular Diagnosis & Therapy is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
ADORA3: A Key Player in the Pathogenesis of Intracranial Aneurysms and a Potential Diagnostic Biomarker143
The Role of MicroRNAs in the Pathogenesis and as Biomarkers for Pediatric Epilepsy: A Systematic Review85
Predictive Ability of Serum Amino Acid Levels to Differentiate Fibromyalgia Patients from Healthy Subjects62
Marnetegragene Autotemcel: First Approval61
Comment on “Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta‑Analysis”60
Considering Tumour Sidedness is Critical for Accurate Interpretation of Liquid Biopsy Results in Metastatic Colorectal Cancer43
Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target43
Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate43
Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors41
Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights40
Evaluation of Minimal Residual Disease in Patients with Neuroblastoma37
FAPI-Targeted Molecular Imaging: Transforming Insights into Post-Ischemic Myocardial Remodeling?35
Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular Models35
Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach34
The Role of Non-coding RNAs in Connective Tissue Diseases: Diagnostic and Therapeutic Potential of miRNAs, lncRNAs and circRNAs34
Research Progress on Signal Conversion Based on Aptamer Combined CRISPR/Cas System in Biosensors32
Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk30
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders27
Correction to: Revakinagene Taroretcel: First Approval27
Fatty Acid Desaturase: The Yin or Yang of Disease Pathology26
Personalizing Oncolytic Immunovirotherapy Approaches26
Advances and Challenges in the Diagnosis of Leishmaniasis25
Development of a Nomogram to Predict Therapeutic Resistance in Metastatic Melanoma Using Longitudinal ctDNA Kinetics25
Inflammatory Gene Panel Guiding the Study of Genetics in Inflammatory Bowel Disease24
Afamitresgene Autoleucel: First Approval23
Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics23
Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges22
Long-Range PCR and Nanopore Sequencing Enables High-Throughput Detection of TCF4 Trinucleotide Repeat Expansions in Fuchs Endothelial Corneal Dystrophy21
Comment on “The Diagnostic and Prognostic Value of miR‑155 in Cancers: An Updated Meta‑analysis”21
Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy20
Molecular Therapeutics in Development to Treat Alzheimer’s Disease20
Diagnosis of Lung Cancer Through Exhaled Breath: A Comprehensive Study20
Development of a New Rapid Simultaneous Molecular Assay for the Detection of STI Pathogens and Drug Resistance-Associated Mutations19
Single Nucleotide Variants in KIF14 Gene May Have Prognostic Value in Breast Cancer19
Performance of a Rapid Digital PCR Test for the Detection of Non-Small Cell Lung Cancer (NSCLC) Variants19
Molecular Dynamics as a Precision Therapy: A Perspective on Epileptic Encephalopathies18
Evolutionary Overview and Future Perspectives: ESR1 Mutations, Liquid Biopsy, and Artificial Intelligence for a New Era of Personalized Medicine in ER+ Breast Cancer17
The Emerging Role of Olfactory Receptors: From Genomics to Precision Medicine17
In vivo LNP-CRISPR Approaches for the Treatment of Hemophilia17
Targeted Therapy in Salivary Gland Cancer: Prevalence of a Selected Panel of Actionable Molecular Alterations in a German Tertiary Referral Center Patient Cohort17
Is the Homologous Recombination Repair Mutation Defined by a 15-Gene Panel Associated with the Prognosis of Epithelial Ovarian Cancer?16
The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis16
Correction to: Molecular Therapeutics in Development to Treat Alzheimer’s Disease15
TROP2-Targeted Therapeutics in Development to Treat Gastrointestinal Tumors15
Neuromuscular Junction as a Molecular Target in Sarcopenia: Mechanisms, Therapeutic Strategies, and Future Directions15
Role of lncRNAs in Remodeling of the Coronary Artery Plaques in Patients with Atherosclerosis15
Lifileucel: First Approval15
Selecting Targets for Molecular Imaging of Gastric Cancer: An Immunohistochemical Evaluation15
Correction: Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders15
The Role οf Ion Channels in the Development and Progression of Prostate Cancer14
Diagnostic Performance of the ASCL1/ZNF582 Methylation Test for Detection of High-Grade Vulvar Intraepithelial Neoplasia and Vulvar Cancer14
Bridging the Gap: Cost-Effective Strategies for Detecting Ph-Like B-Lineage ALL in Resource-Limited Settings14
Comment on “Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta‑Analysis”14
Cytokines at the Crossroads of Mitochondrial Dysfunction and Inflammation in Colorectal Cancer: Implications for Postoperative Complications14
Cell-Free HPV-DNA in Screening, Diagnosis, Prognosis, and Treatment Response Monitoring of Cervical Cancer14
Human Papillomavirus Type and Viral Load in Relation to Circulating Cell-Free Tumour HPV DNA Level and Survival in Cervical Cancer13
Extracellular Histones Profiles of Pediatric H3K27-Altered Diffuse Midline Glioma13
Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of R13
Obecabtagene Autoleucel: First Approval12
Emerging RNAi Therapies to Treat Hypertension12
Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma12
Multiplex RT-PCR-Based Sequencing Assay to Detect Kidney Cancer-Specific Splice Variants in Tumor Tissues and Plasma Cell-Free RNAs12
Fluorescence Imaging-Assessed Surgical Margin Detection in Head and Neck Oncology by Passive and Active Targeting12
Psoriasis: A Multidimensional Review of Onset, Progression, Treatment, and the Evolution of Disease Models12
Author reply to Wang et al.: “The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta‑analysis”11
Future Prospects for Epigenetics in Autism Spectrum Disorder11
Chimeric Genes Causing 11β-Hydroxylase Deficiency: Implications in Clinical and Molecular Diagnosis11
Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab11
Blood Biomarkers of Long COVID: A Systematic Review11
Retroviral Remnants in the Human Genome: Classification, Integration and Regulation11
Inner Ear Gene Therapy: An Overview from Bench to Bedside11
0.47758007049561